NURS 5334 MODULE 7 EXAM LATEST
VERSION 2024-2025
•
Oral decongestants should be avoided in people with
•
A. migraines
•
B. Allergic rhinitis
•
C. Cardiovascular disease
•
D. Chronic bronchitis - ANSWER C: Cardiovascular disease
•
A 19-year-old asthmatic is taken to the emergency department with severe
bronchospasm. The
NP should order:
•
A. nebulized beta-2 agonist
•
B. A salmeterol-type inhaled agonist
•
,C. an oral beta-2 agonist.
•
D. ANSWER A: An inhaled corticosteroid. nebulized beta-2 agonist
•
Concerning the use of long-acting beta 2 agonists (LABAs), which of the
Which of the following is not true?
•
A. LABAs boost the anti-inflammatory properties of corticosteroids.
•
B. The use of LABAs is related with a slight increase in risk of asthma mortality.
•
C. LABA use lowers the likelihood of asthma exacerbations.
•
D. LABAs can be used as monotherapy to alleviate bronchospasms in asthma.
D. LABAs can be used as monotherapy to alleviate bronchospasms in asthma.
•
Dextromethorphan, an antitussive, works to block the cough reflex by:
•
A. Direct action at the cough center
•
, B. Anesthetizing the alpha receptor
•
C. Causes CNS depression.
•
D. Reducing the viscosity of the bronchial secretion
A. Direct action at the cough center
•
Your new ten-year-old patient has asthma, so you decide to treat her using
Beta-2 agonist. Consider the possible pharmacological effects in the patient.
It is worth noting that Beta 2 stimulants usually cause:
•
A. Directly stimulating the renin system
•
B. Hypoglycemia
•
C. Increased histamine release.
•
D. Answer D: Increased pulse rate.
•
VERSION 2024-2025
•
Oral decongestants should be avoided in people with
•
A. migraines
•
B. Allergic rhinitis
•
C. Cardiovascular disease
•
D. Chronic bronchitis - ANSWER C: Cardiovascular disease
•
A 19-year-old asthmatic is taken to the emergency department with severe
bronchospasm. The
NP should order:
•
A. nebulized beta-2 agonist
•
B. A salmeterol-type inhaled agonist
•
,C. an oral beta-2 agonist.
•
D. ANSWER A: An inhaled corticosteroid. nebulized beta-2 agonist
•
Concerning the use of long-acting beta 2 agonists (LABAs), which of the
Which of the following is not true?
•
A. LABAs boost the anti-inflammatory properties of corticosteroids.
•
B. The use of LABAs is related with a slight increase in risk of asthma mortality.
•
C. LABA use lowers the likelihood of asthma exacerbations.
•
D. LABAs can be used as monotherapy to alleviate bronchospasms in asthma.
D. LABAs can be used as monotherapy to alleviate bronchospasms in asthma.
•
Dextromethorphan, an antitussive, works to block the cough reflex by:
•
A. Direct action at the cough center
•
, B. Anesthetizing the alpha receptor
•
C. Causes CNS depression.
•
D. Reducing the viscosity of the bronchial secretion
A. Direct action at the cough center
•
Your new ten-year-old patient has asthma, so you decide to treat her using
Beta-2 agonist. Consider the possible pharmacological effects in the patient.
It is worth noting that Beta 2 stimulants usually cause:
•
A. Directly stimulating the renin system
•
B. Hypoglycemia
•
C. Increased histamine release.
•
D. Answer D: Increased pulse rate.
•
